Structure and cytotoxicity of zinc (II) and cobalt (II) complexes based on 1,3,5‐tris(1‐imidazolyl) benzene

Three novel complexes, [Zn (tib)₂·(H₂O)₂]·(NO₃)₂ ( 1 ), [Co (tib)₂]·2NO₃ ( 2 ) and [Co₂(tib)₂(btc)]·H₂O ( 3 ) [H₄btc = 1,2,4,5‐benzenetetracarboxylic acid; H₂tib = 1,3,5‐tris(1‐imidazolyl)benzene], were synthesized and characterized by single‐crystal X‐ray, IR and elemental analysis. The interaction of these complexes with FS‐DNA (fish sperm DNA) was monitored, and binding constants were determined using UV/Vis, which revealed that they have the ability to bind to FS‐DNA. DNA‐binding constants (K) for the three complexes were 2.2 × 10⁴ m ^?1, 0.7 × 10⁴ m ^?1 and 0.09 × 10⁴ m ^?1, respectively. The interaction capacity of the complexes with FS‐DNA has been investigated by fluorescence spectroscopy. Stern–Volmer quenching plot values for complexes 1 , 2 and 3 were 0.3784, 0.1028 and 0.076, respectively. The viscosity measurement suggested that complexes 1 , 2 and 3 interact with DNA in an intercalation mode. In addition, anti‐cancer activities of these complexes investigated through MTT assays in vitro indicated that the complexes showed good cytotoxic activity against cancer cell lines. Cytotoxic activity of test complexes against two different cancer cell lines (HeLa and KB cells) showed significant cancer cell inhibition rates. Flow cytometry experiments and morphological apoptosis studies showed that the complexes induced apoptosis of HeLa tumor cell lines. Finally, a further molecular docking technique was employed to confirm the binding of the complexes toward the molecular target DNA.     

Synthesis,characterization and biological activities of two novel orthopalladated complexes: Interactions with DNA and bovine serum albumin,antitumour activity and molecular docking studies

[Pd(L₁)(C,N)]CF₃SO₃ and [Pd(L₂)(C,N)]CF₃SO₃ (L₁ = 2,2′ ‐bipyridine, L₂ = 1,10‐phenanthroline and C,N = benzylamine) novel orthopalladated complexes have been synthesized and characterized using various techniques. The binding of the complexes with native calf thymus DNA (CT‐DNA) was monitored using UV–visible absorption spectrophotometry, fluorescence spectroscopy and thermal denaturation studies. Our results indicate that these complexes can strongly bind to CT‐DNA via partial intercalative mode. In addition, fluorescence spectrometry of bovine serum albumin (BSA) with the complexes shows that the fluorescence quenching mechanism of BSA is a static process. The results of site‐competitive replacement experiments with specific site markers clearly indicate that the complexes bind to site I of BSA. Notably, the complexes exhibit significant in vitro cytotoxicity against two human cancer cell lines (Jurkat and MCF‐7) with IC₅₀ values varying from 37 to 53 μM. Finally, a molecular docking experiment effectively proves the binding of the Pd(II) complexes to DNA and BSA.     

Synthesis,crystal structures,DNA binding and cleavage properties and protein binding activities of three mononuclear cobalt(II) complexes

Three new mononuclear cobalt(II) complexes containing ligands with extended planar quinoxaline moieties, {dipyrido[3,2‐a:2′,3′‐c]phenazine (dppz) or dipyrido[3,2‐d:2′,3′‐f]quinoxaline (dpq)}, viz. [Co(dppz)(acac)₂] · CH₃OH ( 1 ), [Co(dpq)(tfnb)₂] ( 2 ) and [Co(dpq)(dbm)₂] ( 3 ), where acac = acetylacetonate, tfnb = benzoyltrifluoroacetone and dbm = dibenzoylmethane, have been synthesized and structurally characterized as octahedral complexes. The binding ability of the complexes with calf thymus (CT)‐DNA has been investigated by spectroscopic and viscosity measurements. Results indicate that all complexes bind to CT‐DNA via intercalative mode, and the DNA binding affinity of dppz complex 1 is apparently stronger than that of dpq complexes 2 and 3 . Furthermore, DNA photocleavage experiments indicate that these complexes are efficient DNA cleaving agents in UV‐A (365 nm) and hydroxyl radical (HO^·), singlet oxygen (¹O₂) and superoxide anion (¹O₂^?) serve as the major cleavage active species. In addition, interaction of the complexes with bovine serum albumin (BSA) was investigated using UV ? visible and fluorescence methods, which indicated that all complexes could quench the intrinsic fluorescence of BSA in a static quenching process. Copyright © 2014 John Wiley & Sons, Ltd.     

Synthesis,characterization, DNA binding,cytotoxicity and molecular docking properties of three novel butterfly-like complexes with nitrogen-containing heterocyclic ligands

Three novel complexes, namely [Nd·L₁·HCOO·(H₂O)₄] ( 1 ), [Pr·L₁·HCOO·(H₂O)₄] ( 2 ) and [In·L₂·Cl·(H₂O)₂] ( 3 ) (L₁ = 1,1-bis(5-(pyrazin-2-yl)-1,2,4-triazol-3-yl)methane, L₂ = 1,1-bis(5-(pyrazin-2-yl)-1,2,4-triazol-3-yl)ketone), were synthesized and characterized. The molecular structures of 1 – 3 were confirmed using single-crystal X-ray diffraction. All three obtained complexes are zero-dimensional and connected to each other by hydrogen bonds. In 1 and 2 the metal is surrounded by nine donors and 3 has seven coordination sites. The interaction of 1 – 3 with calf thymus DNA (CT-DNA) was explored using UV absorption spectra and fluorescence spectra. The intrinsic binding constants of 1 – 3 with CT-DNA are about 1.9 × 10⁴, 1.4 × 10⁴ and 1.1 × 10⁴, respectively. Stern–Volmer quenching plots of 1 – 3 have slopes of 0.1508, 0.134 and 0.1205, respectively. The ability of these complexes to cleave pBR322 plasmid DNA was demonstrated using gel electrophoresis assay. Apoptosis studies of the three novel complexes showed a significant inhibitory effect on HeLa cells. Furthermore, MTT assays were used to evaluate the anticancer activity of the three complexes. The cytotoxicity study indicated that complex 1 possesses a higher inhibitory rate of HeLa cells than the other complexes. Especially, the efficacy of 1 was shown to be the highest for cisplatin at 24 h. A further molecular docking technique was introduced to understand the binding of the complexes toward the target DNA.     

Dimethyltin(IV) complexes derived from hydroxamic acid and acylhydrazone ligands: Synthesis,DNA/bovine serum albumin interaction and cytotoxicity

Two novel dimethyltin(IV) complexes, Me₂SnL¹(PyCOO)(MeOH) ( 1 ) and Me₂SnL² ( 2 ) (HL¹ = 4‐pyridinehydroxamic acid and H₂L² = 2‐hydroxy‐N′‐[(2‐hydroxy‐5‐chlorophenyl)methylidene]benzoylhydrazone), were synthesized and characterized using elemental analyses, Fourier transform infrared and NMR (¹H, ¹³C) spectroscopies and single‐crystal X‐ray diffraction. In complex 1 the geometry around the tin atom is a six‐coordinated distorted octahedral configuration, while complex 2 exhibits five‐coordinated distorted trigonal bipyramid geometry. Preliminary in vitro cytotoxicity studies with two human cancer cell lines (HeLa and A549) using MTT assay show that complex 1 is more potent than complex 2 . The interactions of the two complexes with calf thymus DNA and bovine serum albumin were also investigated using UV–visible absorption spectral, thermal denaturation and viscosity measurements and docking analysis. Investigations indicate that the structures of the mixed ligands play an important role in the properties of the dimethyltin(IV) complexes, and, to some extent, the antitumor activities of the complexes are partly related to interactions with DNA and some proteins in cancer cells.     

Cu (II) tyrosinate complexes containing methyl substituted phenanthrolines: Synthesis,X‐ray crystal structures,biomolecular interactions,antioxidant activity,ROS generation and cytotoxicity

In this paper, three new copper (II) complexes, [Cu(4‐mphen)(tyr)(H₂O)]ClO₄ (1) , [Cu(5‐mphen)(tyr)(H₂O)]ClO₄·1.5H₂O (2) and [Cu (tmphen)(tyr)(NO₃)]0.5H₂O (3) (4‐mphen: 4‐methyl‐1,10‐phenanthroline, 5‐mphen: 5‐methyl‐1,10‐phenanthroline, tmphen: 3,4,7,8‐tetramethyl‐1,10‐phenanthroline and tyr: L‐tyrosine), were synthesized and characterized using elemental analyses, FT‐IR, ESI‐MS, cyclic voltammetry and single‐crystal X‐ray diffraction. It was found that the complexes adopt a distorted five‐coordinate square pyramidal geometry. The interaction of the three complexes with calf thymus DNA was also investigated using UV–visible absorption spectra, ethidium bromide and Hoechst 33258 displacement assay and thermal denaturation. The DNA cleavage activity of the complexes, monitored using gel electrophoresis, showed significant damage of the pUC19 plasmid DNA. Binding activity of bovine serum albumin (BSA) reveals that these complexes can strongly quench the fluorescence of BSA through a static quenching mechanism. The results suggested that interaction of the complexes with DNA occurred through a partial intercalation into the minor grooves of DNA. In addition, interaction of the complexes with bovine serum albumin quenched the fluorescence emission of the tryptophan residues of the protein binding constants and thermodynamic parameters were obtained from the fluorescence quenching experiments at different temperatures. Free radical scavenging activities of the complexes were determined by various in vitro assays such as 1,1‐diphenyl‐2‐picryl‐hydrazyl free radicals (DPPH˙) and H₂O₂ scavenging methods. In addition, the cytotoxicity of these complexes in vitro on tumor cell lines (Caco‐2 and MCF‐7) was examined by XTT and showed better antitumor effect on the tested cells. ROS (reactive oxygen species) and comet experiments are consistent with each other and these complexes lead to DNA damage via the production of ROS. The effect of the hydrophobic properties of the synthesized complexes on DNA and BSA binding activities were discussed.     

Synthesis and characterization of water‐soluble copper(II), cobalt(II) and zinc(II) complexes derived from 8‐hydroxyquinoline‐5‐sulphonic acid: DNA binding and cleavage studies

Three water‐soluble complexes, [Cu₂L₂Cl₂] ( 1 ), [CoL₂(im)₂] ( 2 ) and [ZnLClH₂O] ( 3 ) (HL = 8‐hydroxyquinoline‐5‐sulphonic acid; im = N ‐methylimidazole), were prepared and characterized using various spectral techniques. The DNA binding behaviour of complexes 1 – 3 was studied using UV–visible and circular dichroism (CD) spectra and cyclic voltammetry. All three complexes exhibit hypochromism but complexes 1 and 3 alone give a red shift of 4 nm with a significant binding constant of K _b = 2.1 × 10⁴ and 1.0 × 10⁴ M⁻¹, respectively, but complex 2 shows no red shift with lower K _b of 4.1 × 10³ M⁻¹. The voltammetric E _1/2 of complex 1 on interaction with herring sperm DNA shifts to a more positive potential, as expected, than complex 2 due to higher DNA affinity. Additionally, analysis of electrochemical data yields a value of K ₊/K ₂₊ greater than one suggesting that complex 1 binds to DNA through intercalation in the M(I) state. Evidently in CD spectral analysis, complex 1 exhibits a decrease in molar ellipticity with a red shift of 10 nm and a significant decrease in intensity compared to complexes 2 and 3 . This clearly indicates that complex 1 induces the B → A transition to a greater extent than 2 and 3 . Oxidative cleavage using circular plasmid pUC18 DNA with complex 1 was investigated using gel electrophoresis. Interestingly, complex 1 displays a strong DNA binding affinity and is efficient in cleaving DNA in the presence of H₂O₂ at pH = 8.0 at 37 °C.     

Hexanuclear Zn(II) and Mononuclear Cu(II) Complexes containing imino phenol ligands: Exploitation of their Catalytic and Biological Perspectives

A unique hexanuclear zinc(II) ( 1 ) and two mononuclear copper(II) ( 2 and 3 ) complexes anchored with imino phenol ligand HL ¹ and HL ² were synthesized with good yield and purity (where HL ¹  = 4‐tert‐butyl‐2,6‐bis((mesitylimino)methylphenol and HL ²   =  5‐tert‐butyl‐2‐hydroxy‐3‐((mesitylimino)methyl)benzaldehyde). These complexes were characterized by utilizing various spectroscopic protocols like NMR, FTIR, UV as well as ESI‐Mass spectrometry, elemental analysis and single crystal X‐ray diffraction studies. Their potential to bind calf thymus DNA (CT‐DNA) was tested utilizing different techniques such as UV–visible and fluorescence spectroscopy. The experiment implies that they interact with CT‐DNA via non‐intercalative mode with moderate capabilities (K_b ~ 10⁴ M^?1). On the other hand, these complexes have high capabilities to quench the fluorescence of bovine serum albumin (BSA) following the static pathway. In addition, they are active catalysts for the oxidation reaction of 3,5‐di‐tert‐butylcatechol (3,5‐DTBC) to 3,5‐di‐tert‐butylquinone (3,5‐DTBQ) under aerobic condition. From the recorded EPR signals of all complexes, it has been concluded that the oxidation reaction proceeds via ligand oriented radical pathway instead of metal based redox participation. Kinetic studies using 1 – 3 indicate that it follows Michaelis–Menten type of equation with moderate to high turnover number (k_cat). Apart from these aspects, complexes 1 – 3 were screened for their cytotoxic behavior towards HeLa cells (human cervical carcinoma) and found quite active with comparable IC₅₀ values to cisplatin.     

Isomeric Effect on the anticancer Behavior of two Zinc (II) complexes based on 3,5‐bis(1‐imidazoly) pyridine: Experimental and Theoretical Approach

Two isomeric Zinc (II) complexes constructed by 3,5‐bis(1‐imidazoly) pyridine has been synthesized and characterized by single crystal X‐ray diffraction, elemental analyses and infrared spectroscopy. The binding mode and ability of complex 1–2 with CT‐DNA were studied by UV and fluorescence spectra. The intrinsic binding constant K_b (K_b1 = 2.305 × 10⁴ M^?1, K_b2 = 3.095 × 10⁴ M^?1) and the observed association constant K_obs (K_obs1 = 1.523*10⁶ M^?1, K_obs2 = 2.057*10⁶ M^?1) indicated that the insertion ability of complex 2 with CT‐DNA is stronger than complex 1. Gel electrophoresis showed that complexes have a good ability to hydrolyze cleavage pBR322 plasmid DNA. The cytotoxicity and apoptosis studies showed that complexes exhibited excellent cytotoxic activity against HeLa cells, especially complex 2 had better growth inhibition than Cisplatin. Molecular docking study simulated the binding model of complexes with DNA (PDB:4av1), showing an imidazole plane of complex 2 can be inserted into a DNA base pair in relative parallel. Both complexes can be used as potential anticancer agents.     

Two MnII,CuII complexes derived from 3,5‐bis(1‐imidazoly) pyridine: Synthesis,DNA binding,Molecular docking and cytotoxicity studies

Two complexes [MnL₂ (H₂O)₂]·2ClO₄ (complex 1) and [CuL(H₂O)₃]·2NO₃ (complex 2) (where L = 3,5‐bis(1‐imidazoly) pyridine) were designed and synthesized. The structures of the complexes were characterized by X‐ray crystallography, elemental analyses, and infrared spectrum. The interaction capacity of the complexes with calf thymus DNA has been investigated by UV and fluorescence spectroscopy. Gel electrophoresis assay demonstrated the ability of the complexes to cleave the pBR322 plasmid DNA. Efficient binding properties of DNA were established by UV–vis, fluorescence, and gel electrophoresis. The intrinsic binding constants (K_b) were calculated to be 0.1524, 0.1041 for complexes 1–2, respectively. The cytotoxic activity of the two complexes exhibited a higher cytotoxicity against HeLa cell lines and lower cytotoxicity toward the normal cell lines. Flow cytometry demonstrated the cancer cell inhibitory rate of two complexes. Furthermore, computer‐aided molecular docking studies were performed to visualize the binding mode of the drug candidate at the molecular level. Interestingly, complex 1 exhibited a significant cancer cell inhibitory rate than cisplatin and other complexes.     

Organoruthenium (II) complexes featuring pyrazole‐linked Schiff base ligands: Crystal structure,DNA/BSA interactions,cytotoxicity and molecular docking

Half‐sandwiched ruthenium (II) arene complexes with piano stool‐like geometry with the general formula [(p‐cymene)RuClL¹] and [(p‐cymene)RuClL²] [where L¹ = (Z)‐N′‐((1,3‐diphenyl‐1H‐pyrazol‐4‐yl)methylene)furan‐2‐carbohydrazide and L² = (Z)‐N′‐((1,3‐diphenyl‐1H‐pyrazol‐4‐yl)methylene)thiophene‐2‐carbohydrazide] were synthesized and characterized. The single crystal X‐ray data revealed that the complexes belong to the same crystal system (monoclinic) with octahedral geometry, where the ruthenium atom is surrounded by hydrazone ligand coordinated through ON atoms, one chloride labile co‐ligand and the remaining three coordination sites covered by an electron cloud of p‐cymene moiety. The interaction between the complexes and DNA/bovine serum albumin (BSA) was evaluated using absorption and emission titration methods showing intercalative modes of interaction. The DNA cleavage ability of the complexes was checked by agarose gel electrophoresis method exhibiting the destruction of DNA duplex arrangement. To understand the interaction between ruthenium complex and DNA/BSA molecule, molecular docking studies were performed. In vitro cytotoxicity of the complexes was examined by the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay on human lung cancer cell line, A549, and found that at lower IC₅₀, cell growth inhibition has occurred. Similarly, the IC₅₀ values of the complexes treated with cancerous cell lines have produced a significant amount of lactase dehydrogenase and nitrite content in the culture medium, which were evaluated as apoptosis‐inducing factors, suggesting that the ruthenium (II) arene hydrazone complexes with pyrazole ligands have promising anticancer activities.     

Complexes of Co (II) and Cu (II) with nonsteroidal anticancer drug Letrozole and their interaction with DNA and BSA by spectroscopic methods and cytotoxic activity

DNA and BSA binding properties of mononuclear Co (II) and Cu (II) complexes containing letrozole [M(Le)₄Cl₂]·(H2O)](Le=[4,4-(1H-1,2,4-triazol-1-ylmethylene)bisbenzonitrile] have been investigated under physiological conditions. The interaction ability of the two complexes with native calf thymus DNA(CT-DNA) has been monitored as a function of the metal complex-DNA molar ratio by UV–Vis absorption spectrophotometry, fluorescence spectroscopy, circular dichroism(CD) and thermal denaturation studies. The intrinsic binding constants, K_b, of complexes 1 and 2 with CT-DNA, obtained from UV–Vis absorption studies, were 3.15 ± 0.02 × 10⁴ and 4.37 ± 0.02 × 10⁴ M^?1, respectively. The addition of the complexes to CT-DNA (1:2) leads to an increase in the melting temperature of DNA up to around 4 °C, which has revealed that complexes could interact with DNA through intercalation mode. Fluorimetric studies have been performed using methylene blue (MB) as a fluorescence probe and competitive studies have shown the ability of the complexes to displace the DNA-bound MB, suggesting competition with MB. To explore the potential biological value of the complexes, the binding interaction between Co (II) and Cu (II) complexes and bovine serum albumin (BSA) has also been studied by fluorescence spectroscopy. The results indicate that the reaction between the complexes and BSA is a static quenching procedure. The site marker displacement experiment has suggested the location of the complexes binding to BSA at Sudlow’s site I in subdomain IIA. Finally, MTT assay studies have shown that the bioactive complexes exert significantly high selective dose-dependent cytotoxicity against a panel of cancer cell lines including MCF-7, JURKAT, SKOV3 and U87.     

Novel organotin (IV) complexes derived from 4,4′‐oxybisbenzoic acid: synthesis,structure, in vitro cytostatic activity and binding interaction with BSA

Six novel organotin (IV) complexes, [(Me₃Sn)₂(H₂O)₂L] ( 1 ), [(R₃Sn)₂L]_n (R = Me 2 , R = n‐Bu 3 ), [(Ph₃Sn)₂L] ( 4 ), [Me₂SnL]_n ( 5 ), [(Me₂Sn)₂L(μ₃‐O)]_n ( 6 ) have been designed and synthesized by the reactions of 4,4′‐oxybisbenzoic acid (H₂L) and triorganotin (IV) chloride or oxide. All the complexes have been characterized by elemental analysis, FT‐IR, NMR, ESI‐Mass, PXRD and X‐ray crystallography. The single crystal diffraction reveals that complexes 1 and 4 represent dinuclear tin monomers. Complexes 2 and 3 display 2D network structure and 2D corrugated framework respectively, which both contain tetranuclear 36‐membered macrocycles. Furthermore, 2D structures are linked into a 3D supramolecular structures through intermolecular C‐H ··· π interactions. Complex 5 shows 1D infinite helical chain and further constructs 3D ladder supramolecular architecture through additional Sn ··· O and C‐H ··· O intermolecular interactions. Complex 6 displays 1D infinite polymeric chain containing 28‐membered macrocyclic ring. Preliminarily in vitro cytostatic activity studies on cervical carcinoma cell lines (HeLa) and hepatocellular carcinoma cell lines (HepG‐2) by MTT assay for some complexes reveal that complexes 3 and 4 exhibit high cytostatic activity. Further, complexes 3 and 4 were selected to investigate interactions of bovine serum albumin (BSA) by fluorescence quenching spectra and synchronous fluorescence spectra, which indicates that the complexes could quench the intrinsic fluorescence of BSA in a static quenching process.     

Metal(II) complexes of bioactive aminonaphthoquinone-based ligand: synthesis,characterization and BSA binding,DNA binding/cleavage,and cytotoxicity studies

An aminonaphthoquinone ligand, L, and its metal complexes of general formula [MLCl₂] {M = Co(II), Ni(II), Cu(II) and Zn(II)} have been synthesized and characterized by analytical and spectral techniques. Tetrahedral geometry has been assigned to Ni(II) and Zn(II) complexes and square planar geometry to Co(II) and Cu(II) complexes on the basis of electronic spectral and magnetic susceptibility data. The binding of complexes with bovine serum albumin (BSA) is relatively stronger than that of free ligand and alters the conformation of the protein molecule. Interaction of these complexes with CT-DNA has been investigated using UV-Vis and fluorescence quenching experiments, which show that the complexes bind strongly to DNA through intercalative mode of binding (K_app 10⁵ M^?1). Molecular docking studies reiterate the mode of binding of these compounds with DNA, proposed by spectral studies. The ligand and its complexes cleave plasmid DNA pUC18 to nicked (Form II) and linear (Form III) forms in the presence of H₂O₂ oxidant. The in vitro cytotoxicity screening shows that Cu(II) complex is more potent against MCF-7 cells and Zn(II) complex exhibits marked cytotoxicity against A-549 cells equal to that of cisplatin. Cell imaging studies suggested apoptosis mode of cell death in these two chosen cell lines.     

Study on Interactions of Phenolic Acid-Like Drug Candidates with Bovine Serum Albumin by Capillary Electrophoresis and Fluorescence Spectroscopy

The interactions of the phenolic acids cinnamic acid (CNA), ferulic acid (FA), caffeic acid (CA) and chlorogenic acid (CLA) with bovine serum albumin (BSA) were investigated and compared using affinity capillary electrophoresis (ACE) and the fluorescence quenching methods. ACE gives binding constants (K _b) and thermodynamic parameters. The thermodynamic parameters show that each of four phenolic acids bind to BSA mainly by hydrogen bonds, electrostatic and hydrophobic interactions. The fluorescence quenching method provided quenching constant K _sv, binding site number n and K _b. The fluorescence results indicate that BSA fluorescence quenching is mainly a static quenching process. The binding constants (K _b) of CNA, FA, CA and CLA were from 2.52×10⁴ to 7.90×10⁴ L⋅mol⁻¹ from ACE experiments and 1.19×10⁴ to 5.21×10⁴ L⋅mol⁻¹ from fluorescence, their increase corresponded to the increase in the number of hydroxyl groups. These results imply that molecular structure and the number of hydroxyl groups of phenolic acids play act key roles in the affinity of natural phenolic acids towards BSA.     

A New Samarium(III) Complex of Liriodenine: Synthesis,Crystal Structure,Antitumor Activity,and DNA Binding Study

A novel Sm^III complex [Sm^III(LA)₂(pic)₃] (Hpic = picric acid), in which LA is a natural‐derived alkaloid, liriodenine, was synthesized and characterized by IR, elemental analysis, and single‐crystal X‐ray diffraction analysis. This complex showed enhanced solubility compared with liriodenine and its metal complexes that have been previously reported. The interaction of the Sm^III complex with ct‐DNA was further investigated by various spectroscopic techniques, such as UV/Vis spectroscopy, fluorescence spectroscopy, circular dichroism spectroscopy (CD), and viscosity measurement. The results showed that the intrinsic binding constant K_b of the Sm^III complex with ct‐DNA was calculated to be 5.03 × 10³ L·mol^–1 by UV/Vis absorption spectral analysis. The thermodynamic fluorescent spectral analysis suggested that the fluorescence intensity of the Sm^III complex was weakened by ct‐DNA mainly through a dynamic quenching mechanism. The presence of Sm complex could increase the viscosity of DNA solution, so it was concluded that the complex bound with ct‐DNA via a moderate intercalative mode. Furthermore, this Sm^III complex exhibited significant growth inhibition on the three typical tumor cell lines, HepG2, T‐24, and SK‐OV‐3, with the corresponding IC₅₀ values, 10.76 ± 0.19, 8.85 ± 1.12, and 10.01 ± 0.55 μM, respectively. The in vitro antitumor activity was comparable with LA and cisplatin, which suggested that it might be a new broad spectrum antitumor agent with more satisfying solubility.     

Synthesis,characterization, DNA binding,cytotoxicity and molecular docking properties of Cu (II) and Mn (II) complexes with 1,4‐bis (pyrazol‐1‐yl) terephthalic acid

Two novel complexes, [Cu (L)(H₂O)]?H₂O ( 1 ) and [Mn (H₂O)₆] ?L ?H₂O ( 2 ) (L = 1,4‐bis (pyrazol‐1‐yl) terephthalic acid), were synthesized under hydrothermal conditions. They were characterized using elemental analysis, infrared spectroscopy and single‐crystal X‐ray diffraction. Intramolecular weak interactions, such as hydrogen bonds, and intermolecular interactions play important roles in the construction of the complexes. The interaction of these complexes with fish sperm DNA (FS‐DNA) was monitored and binding constants were determined using UV–visible spectroscopy, which revealed their ability to bind to FS‐DNA, with binding constants for the two complexes of 1.88 × 10⁴ M^?1 ( 1 ) and 1.06 × 10⁴ M^?1 ( 2 ). Viscosity experiments further demonstrated the binding of the complexes to DNA. The complexes were further studied using gel electrophoresis assay with supercoiled plasmid pBR322 DNA. In addition, anticancer activities of the metal complexes investigated through MTT assays in vitro indicated good cytotoxic activity against cancer cell lines. Flow cytometry and apoptosis experiments showed that these complexes induced apoptosis of two different cancer cell lines (HeLa and KB cells), demonstrating a significant cancer cell inhibitory rate. Finally, a further molecular docking technique was employed to confirm the binding of the complexes towards the molecular target DNA.     

Investigation on sonocatalytic damage of BSA under ultrasonic irradiation by Fe<Superscript>III</Superscript> complexes with some aminocarboxylic acid

The interaction of BSA and Fe^III complexes ([Fe^III(gly)(H₂O)₄]²⁺, [Fe^III(ida)(H₂O)₃]⁺, and [Fe^III(nta)(H₂O)₂], gly—glyane, ida—iminodiacetic acid, nta—triglycolamic acid) as well as the sonocatalytic damage to BSA was studied by UV-vis and fluorescence spectra. In addition, the influences of ultrasonic irradiation time and Fe^III complex concentration were also examined on the sonocatalytic damage to BSA. The results showed that the fluorescence quenching of BSA solution caused by the Fe^III complexes belonged to the static quenching process. The BSA and Fe^III complexes interacted with each other mainly through weak interaction and coordinate actions. The binding association constants (K) and binding site numbers (n) were calculated. The results were as follows: K ₁ = 0.5353 × 10⁴ l mol⁻¹ and n ₁ = 0.9812 for [Fe^III(gly)(H₂O)₄]²⁺, K ₂ = 1.4285 × 10⁴ l mol⁻¹ and n ₂ = 1.0899 for [Fe^III(ida)(H₂O)₃, and K ₃ = 0.4411 × 10⁴ l mol⁻¹ and n ₃ = 0.9471 for [Fe^III(nta)(H₂O)₂]. Otherwise, under ultrasonic irradiation the BSA were obviously damaged by the Fe^III complexes. The damage degree rose up with the increase of ultrasonic irradiation time and Fe^III complex concentration. And that, [Fe^III(nta)(H₂O)₂] exhibited in a way higher sonocatalytic activity than [Fe^III(gly)(H₂O)₄]²⁺ and [Fe^III(ida)(H₂O)₃]⁺.     

Spectroscopic studies,structural characterization and electrochemical studies of two cobalt (III) complexes with tridentate hydrazone Schiff base ligands: Evaluation of antibacterial activities,DNA‐binding,BSA interaction and molecular docking

Co(III) complexes of tridentate Schiff base ligands derived from N‐(2‐hydroxybenzylideneamino)benzamide (H ₂ L ¹ ) and 2‐(2‐hydroxybenzylidene)hydrazine‐1‐carboxamide ( H ₂ L ² ) were synthesized and characterized using IR, Raman, ¹H–NMR and UV–Vis spectroscopies. X‐ray single crystal structures of complexes 1 and 2 have also been determined, and it was indicated that these Co(III) complexes are in a distorted octahedral geometry. The cyclic voltammetry (CV) of the complexes indicates an irreversible redox behavior for both complexes 1 and 2 . The antibacterial effects of the synthesized compounds have been tested by minimum inhibitory concentration and minimum bactericidal concentration methods, which suggested that the metal complexes exhibit better antibacterial effects than the ligands against Gram‐positive bacteria. The effects of the drug (drug  =  ligands and complexes) on bovine serum albumin (BSA) were examined using circular dichroism (CD) spectropolarimetry, and it was revealed that the BSA (BSA, as a carrier protein) secondary structure changed in the presence of the drug. Interaction of the drug with calf‐thymus DNA (CT‐DNA) was investigated by UV–Vis absorption, fluorescence emission, CV and CD spectroscopy. Binding constants were determined using UV–Vis absorption. The results indicated that the studied Schiff bases bind to DNA, with the hyperchromic effect and non‐intercalative mode in which the metal complexes are more effective than ligands. Furthermore, molecular docking simulation was used to obtain the energetic and binding sites for the interaction of the complexes with Mycobacterium tuberculosis enoyl‐acyl carrier protein reductase (InhA), and results showed that complex 1 has more binding energy.     

Cytotoxic and DNA-binding properties of two ruthenium(II) porphyrin complexes

Two ruthenium(II) porphyrin complexes [Ru(L)₂Cl(PTP)]⁺ (L = bpy, 1, phen; 2; PTP = 5-(3′-pyridyl)-10,15,20-trimethylphenylporphyrin) have been synthesized and their antitumor activities have been evaluated by MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) methods. Both complexes exhibit high inhibitory activity against the growth of human cervical carcinoma cell line HeLa, both with and without light treatment. However, when treated with light, the inhibitory activity for both complexes increases at low drug concentration. Spectroscopic studies show that both complexes can bind to HeLa DNA tightly with apparent binding constants of 1.54(±0.07) × 10⁵ and 1.01(±0.02) × 10⁵ M⁻¹ for 1 and 2, respectively.